Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK-104-CR vs IR Pitavastatin PK/Safety in Healthy Volunteers
NCT02634034Phase 1Completed
- Start
- Dec 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pitavastatin in hyperlipidemia (3 arms). Primary endpoint: Area Under the Curve. Started Dec 2015; status: completed.
02
Drugs
pitavastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02634034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02634034.